Search research articles
Contact Us
Filters
Showing results (261-270 of 331) with videos related to
Page
of 34
Sort By:
Clinical and Translational Radiation Oncology
|
June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
Amit Roy, Randall J Brenneman, Jacob Hogan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 4, 2026
Phase 1 trial of pre-operative image guided intensity modulated photon radiotherapy with simultaneously integrated boost to the high-risk margin for patients with retroperitoneal sarcoma
Kevin X Liu, Yen-Lin Chen, Beow Y Yeap, et al.
International Journal of Environmental Research and Public Health
|
December 29, 2020
Maternal Exposure to Disinfection By-Products and Risk of Hypospadias in the National Birth Defects Prevention Study (2000-2005)
Ibrahim Zaganjor, Thomas J Luben, Tania A Desrosiers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 3, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926
Douglas M Dahl, Joseph P Rodgers, William U Shipley, et al.
Practical Radiation Oncology
|
January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life
William C Jackson, Robert T Dess, Dale W Litzenberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 7, 2020
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines
Romaana Mir, Sarah M Kelly, Ying Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer
W Robert Lee, James J Dignam, Mahul B Amin, et al.
Journal of Neuro-Oncology
|
February 7, 2018
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients
Arif N Ali, Peixin Zhang, W K Alfred Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
Daniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
The Journal of Urology
|
September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment
Peter Chang, Meredith M Regan, Montserrat Ferrer, et al.
Page
of 34
Search research articles
Search
Showing results (261-270 of 331) with videos related to
Sort By:
Page
of 34
Clinical and Translational Radiation Oncology
|
June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
Amit Roy, Randall J Brenneman, Jacob Hogan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 4, 2026
Phase 1 trial of pre-operative image guided intensity modulated photon radiotherapy with simultaneously integrated boost to the high-risk margin for patients with retroperitoneal sarcoma
Kevin X Liu, Yen-Lin Chen, Beow Y Yeap, et al.
International Journal of Environmental Research and Public Health
|
December 29, 2020
Maternal Exposure to Disinfection By-Products and Risk of Hypospadias in the National Birth Defects Prevention Study (2000-2005)
Ibrahim Zaganjor, Thomas J Luben, Tania A Desrosiers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 3, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926
Douglas M Dahl, Joseph P Rodgers, William U Shipley, et al.
Practical Radiation Oncology
|
January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life
William C Jackson, Robert T Dess, Dale W Litzenberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 7, 2020
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines
Romaana Mir, Sarah M Kelly, Ying Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer
W Robert Lee, James J Dignam, Mahul B Amin, et al.
Journal of Neuro-Oncology
|
February 7, 2018
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients
Arif N Ali, Peixin Zhang, W K Alfred Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
Daniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
The Journal of Urology
|
September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment
Peter Chang, Meredith M Regan, Montserrat Ferrer, et al.
Page
of 34